| Barrett Thompson, MD | |
|
1815 Gunbarrel Rd, Chattanooga, TN 37421-3130 | |
| (423) 803-2020 | |
| Not Available |
| Full Name | Barrett Thompson |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 1815 Gunbarrel Rd, Chattanooga, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659938181 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 068126 (Tennessee) | Primary |
| Entity Name | Deborah R. Distefano M.d.p.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588855225 PECOS PAC ID: 0840286225 Enrollment ID: O20040421001559 |
News Archive
Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that APP Pharmaceuticals will immediately begin marketing Anastrozole tablets in the U.S., after the U.S. Food and Drug Administration granted approval to market the breast cancer treatment medication to Fresenius Kabi Oncology Limited.
Politico: "President Barack Obama told House Republicans Friday that Washington can't break through partisan gridlock 'if we can't move past the politics of no' — then engaged with them in an extraordinary back-and-forth straight out of the House of Commons."
Approval is the most significant advancement in the treatment of chronic kidney disease in more than 20 years. In DAPA-CKD Phase III trial, Farxiga demonstrated unprecedented reduction in the risk of the composite of worsening of renal function, end-stage kidney disease and cardiovascular or renal death.
PPD, Inc. today confirmed that Takeda Pharmaceutical Company Limited's new drug application for NESINA® (alogliptin), a highly selective DPP-4 inhibitor for the treatment of type 2 diabetes, was approved by the Japanese Ministry of Health, Labour and Welfare on April 16. PPD's compound partnering division collaborated with Takeda to develop this product.
› Verified 6 days ago
| Entity Name | Precision Eye Consultants |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194405761 PECOS PAC ID: 7416311329 Enrollment ID: O20230912000138 |
News Archive
Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that APP Pharmaceuticals will immediately begin marketing Anastrozole tablets in the U.S., after the U.S. Food and Drug Administration granted approval to market the breast cancer treatment medication to Fresenius Kabi Oncology Limited.
Politico: "President Barack Obama told House Republicans Friday that Washington can't break through partisan gridlock 'if we can't move past the politics of no' — then engaged with them in an extraordinary back-and-forth straight out of the House of Commons."
Approval is the most significant advancement in the treatment of chronic kidney disease in more than 20 years. In DAPA-CKD Phase III trial, Farxiga demonstrated unprecedented reduction in the risk of the composite of worsening of renal function, end-stage kidney disease and cardiovascular or renal death.
PPD, Inc. today confirmed that Takeda Pharmaceutical Company Limited's new drug application for NESINA® (alogliptin), a highly selective DPP-4 inhibitor for the treatment of type 2 diabetes, was approved by the Japanese Ministry of Health, Labour and Welfare on April 16. PPD's compound partnering division collaborated with Takeda to develop this product.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Barrett Thompson, MD 1114 W Mississippi Ave, Chattanooga, TN 37405-2862 Ph: (423) 584-2327 | Barrett Thompson, MD 1815 Gunbarrel Rd, Chattanooga, TN 37421-3130 Ph: (423) 803-2020 |
News Archive
Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that APP Pharmaceuticals will immediately begin marketing Anastrozole tablets in the U.S., after the U.S. Food and Drug Administration granted approval to market the breast cancer treatment medication to Fresenius Kabi Oncology Limited.
Politico: "President Barack Obama told House Republicans Friday that Washington can't break through partisan gridlock 'if we can't move past the politics of no' — then engaged with them in an extraordinary back-and-forth straight out of the House of Commons."
Approval is the most significant advancement in the treatment of chronic kidney disease in more than 20 years. In DAPA-CKD Phase III trial, Farxiga demonstrated unprecedented reduction in the risk of the composite of worsening of renal function, end-stage kidney disease and cardiovascular or renal death.
PPD, Inc. today confirmed that Takeda Pharmaceutical Company Limited's new drug application for NESINA® (alogliptin), a highly selective DPP-4 inhibitor for the treatment of type 2 diabetes, was approved by the Japanese Ministry of Health, Labour and Welfare on April 16. PPD's compound partnering division collaborated with Takeda to develop this product.
› Verified 6 days ago
Dr. Thomas M Reynolds, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2158 Northgate Park Ln, Suite 302, Chattanooga, TN 37415 Phone: 423-870-4900 Fax: 423-870-5889 | |
Carey Cameron Dozier, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 932 Spring Creek Rd, East Ridge Eye Center, Chattanooga, TN 37412 Phone: 423-894-1453 Fax: 423-899-8022 | |
Dr. John L Stone, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7300 Jarnigan Rd, Chattanooga, TN 37421 Phone: 423-664-3366 Fax: 423-531-2925 | |
Dr. Fred Marshall Gregg Iii, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 725 Glenwood Dr, Suite 892, Chattanooga, TN 37404 Phone: 423-624-3937 Fax: 423-629-6505 | |
Mr. Harry M. Lawrence, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 1042 E 3rd St, Ste 102, Chattanooga, TN 37403 Phone: 423-265-1651 Fax: 423-756-0050 | |
Mrs. Molly R Seal, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1042 E 3rd St, Ste 102, Chattanooga, TN 37403 Phone: 423-265-1651 Fax: 423-756-0050 | |
Dr. John Whitman Prenshaw, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7320 Shallowford Rd, Chattanooga, TN 37421 Phone: 423-894-5300 |